Showing 10 from 27 results
Contact Us | Teva Biosimilars
For healthcare professionals or patients with specific medical questions for Teva, please contact us here
Accessibility arrangements by Teva | Teva Biosimilars
Teva makes its best efforts and invests many resources in order to provide all our customers with an equal, respectable, accessible and professional service.
Biosimilar Costs: Using analytics to potentially lower costs | Teva Biosimilars
Teva is leveraging advanced bioanalytics to help lower the cost of drug development.
Biosimilar Manufacturing: Automation and Efficiency | Teva Biosimilars
Teva has invested over $500 million dollars to build a new state-of-the-art biological manufacturing plant in Ulm Germany.
A global manufacturer of generic medicines and APIs | Teva
Last year, Teva shipped over 600,000 pallets globally across 45 countries, including 150,000 pallets in the US.
Advocating for more efficient Biosimilar Regulatory Pathways and Biosimilar Regulations
The more Teva Biosimilars can do to advocate for a more cost effective approach for the process, we believe the more sustainable the future for biosimilars.
We value our partnerships | Teva Biosimilars
Teva Biosimilars understands the value of strategic partnerships.
Biosimilars Development Programs | Teva Biosimilars
Teva is determined to lead the way in innovating quality, affordable and accessible biosimilars.